Similar articles

• [Adjuvant chemotherapy in colonic cancers].

  Grandjouan S, Fabri MC. Grandjouan S, et al. Ann Chir. 1994;48(4):320-7; discussion 328-31. Ann Chir. 1994. PMID: 8085756 Review. French. No abstract available.
• [Adjuvant treatment of resected colon cancers using a 5-fluorouracil-levamisole combination].

  Ducreux M. Ducreux M. Gastroenterol Clin Biol. 1991;15(8-9):665-7. Gastroenterol Clin Biol. 1991. PMID: 1752386 French. No abstract available.
• [Comparison of fluorouracil + folinic acid, fluorouracil + levamisole and fluorouracil + folinic acid + levamisole in Dukes' B and C colon cancer: NSABP Trial C-04].

  Schumacher K. Schumacher K. Strahlenther Onkol. 2000 May;176(5):239-40. Strahlenther Onkol. 2000. PMID: 10847122 Clinical Trial. German. No abstract available.
• Adjuvant therapy of colorectal cancer.

  Kemeny N, Saltz L, Cohen A. Kemeny N, et al. Surg Oncol Clin N Am. 1997 Oct;6(4):699-722. Surg Oncol Clin N Am. 1997. PMID: 9309089 Review.
• Importance of 5-fluorouracil dose-intensity in a double randomised trial on adjuvant portal and systemic chemotherapy for Dukes B2 and C colorectal cancer.

  Focan C, Bury J, Beauduin M, Herman ML, Vindevoghel A, Lecomte M, Brohée D, Canon JL, Focan-Henrard D; GRECCR Belgium. Focan C, et al. Anticancer Res. 2000 Nov-Dec;20(6C):4665-72. Anticancer Res. 2000. PMID: 11205198 Clinical Trial.